Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2008
05/21/2008CN101184502A Polypeptides
05/21/2008CN101182534A Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
05/21/2008CN101182524A Gene for regulating and controlling tillering angle of paddy rice, encoded protein and applications thereof
05/21/2008CN101182522A Arabidopis thaliana salt tolerance gene SRAT1 and uses thereof
05/21/2008CN101182519A P gene order of diffused large B cell lymphoid tumor related antigen specific TCR V Alpha 23 subfamily
05/21/2008CN101182518A Y gene order of diffused large B cell lymphoid tumor related antigen specific TCR V Beta 13 subfamily
05/21/2008CN101182360A Fusion protein having antibiotic function and uses thereof
05/21/2008CN101182358A Purification method for preparing antler collagen
05/21/2008CN101182357A Globefish skin active collagen and method for preparing peptide thereof
05/21/2008CN101182356A Clenbuterol complete antigen and method for preparing monoclonal antibody thereof
05/21/2008CN101182355A Antibacterial peptide fusion protein gene, recombinant carrier thereof, transformant and expression product thereof
05/21/2008CN101182354A Vegetable drought-resistance related protein as well as coding gene and application thereof
05/21/2008CN101182353A Rice stress-tolerance related receptor protein OsSIK1 as well as coding gene and application thereof
05/21/2008CN101182352A Transcription activating factor as well as coding gene and application thereof
05/21/2008CN101182351A Antibiotic peptide as well as preparation method and application thereof
05/21/2008CN101182350A Micrococcus pyogenes alpha-hemolysin and coded sequence thereof
05/21/2008CN101182348A Preparation method of frozen sericin gel
05/21/2008CN101181236A Exendin agonist peptide formulations and administration method thereof
05/21/2008CN100389200C Plant with improved organogenesis and method of preparing the same
05/21/2008CN100389197C Gene constructed expression purification of trap receptor 3 and specificity discrimination thereof
05/21/2008CN100389192C Substances for preventing and treating autoimmune diseases
05/21/2008CN100389126C Endothelial cell proliferation inhibitor and method of use
05/21/2008CN100389125C Rana grahami propyl sperm peptide, gene and variant and its pharmaceutical use
05/21/2008CN100389124C Non-inducing expressing gene engineering strain and structural process and application thereof
05/20/2008US7375264 Inbred corn line PHACV
05/20/2008US7375259 Solanum tuberosum sterol alkaloid glycosyltransferase (SGT) a novel solanidine glucosyltransferase SGT2 and uses thereof
05/20/2008US7375258 Transgenic avians with an ovomucoid gene expression control region linked to a nucleotide sequence encoding a heterologous polypeptide
05/20/2008US7375230 Using transgenic streptomyces to ferment polyketide for use in the treatment of cancer
05/20/2008US7375208 nucleic acid sequences comprising monocotyledonous regulatory sequences that are located upstream of the 5' end of structural coding sequences and transcribed in monocotyledonous tissue, more specifically in wheat tissue preferably lemma, palea or glume
05/20/2008US7375207 Galanin receptor 2 proteins and nucleic acids
05/20/2008US7375206 Brother of the regulator of imprinted sites (BORIS)
05/20/2008US7375204 reporter system reflecting the transport process that transports GPI-anchored proteins to the cell wall was constructed and compounds inhibiting this process were discovered; antifungal agents; inhibiting expression of cell wall glycoproteins and preventing pathogens from showing pathogenicity; DNA
05/20/2008US7375203 thermal receptor ion channel protein, CMR1; potential targets for the treatment of pain; modulates responses to cold stimuli and belongs to the transient receptor potential TRP family; expression vector; recombinant host cell; hot and cold sensations in neuronal tissues
05/20/2008US7375201 derived from Halcurias sp. L sea anemone and not Aequorea victoria and having a novel primary structure; recombinant vector; excitation maximum wavelength is 494 nm, and the fluorescence maximum wavelength is 506 nm; marker protein; reporter protein to determine promoter activity
05/20/2008US7375199 Cancer-associated genes
05/20/2008US7375196 PRO19814 antibodies
05/20/2008US7375195 Vectors with DNA encoding pro polypeptides
05/20/2008US7375190 Modified phosphoribosylaminoimidazole carboxylase (ADE2) for use in identifying modulators for treatment and prevention of neurodegenerative disease
05/20/2008US7375189 administering adiponectin, which inhibits the actions of TGFB and PDGF on hepatic stellate cells and thereby exerts effects of suppressing hepatic fibrosis and promoting the proliferation of normal hepatocytes; treating liver cirrhosis or chronic hepatitis
05/20/2008US7375188 Vegetarian protein a preparation and methods thereof
05/20/2008US7375187 Alzheimer's disease secretase, APP substrates therefor, and uses therefor
05/20/2008US7375186 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections
05/20/2008US7375182 Growth factor homolog zvegf4
05/20/2008US7375179 PRO19680 polypeptides
05/20/2008US7375117 Polypeptides
05/20/2008US7375093 Nuclear receptor-based inducible gene expression system
05/20/2008US7375092 Blocking mitosis; transfection nucleic acid; anticancer agents
05/20/2008US7375091 Comprising a HER-2/neu extracellular domain fused to a HER-2/neu phosphorylation domain, wherein the protein is capable of producing an immune response in a warm-blooded animal.
05/20/2008US7375086 Comprises muropeptides which activate nuclear factor kappa B; drug screening; inflammatory bowel diseases; Nucleotide sequences coding protein for use in the treatment of crohn's disease
05/20/2008US7375080 Microbiocides; reducing microorganisms in foods
05/20/2008US7375079 Recombinant expression system for production of a peptide capable of inhibiting the protease activity of Botulinum toxin B or tetanus toxin which expression system comprises a nucleotide sequence encoding the peptide operably linked to a control sequence for effecting expression
05/20/2008US7375075 For therapy of cancer
05/20/2008US7375074 Ligand which binds to polypeptides; controlling eating disorders; screening process
05/20/2008US7374936 Generation of therapeutic radioconjugate; load isotope onto binding support, elute long lived isotopes, join isotope to targeting particle, recover radioconjugate
05/20/2008US7374935 Human Rgr oncogene and truncated transcripts thereof detected in T cell malignancies, antibodies to the encoded polypeptides and methods of use
05/20/2008US7374931 Vaccine against staphylococcus intoxication
05/20/2008US7374930 GLP-1 gene delivery for the treatment of type 2 diabetes
05/20/2008US7374923 cleaves the insulin-like growth factor binding proteins 3 and 5; screening for a therapeutic agent for type II diabetes, particularly for alleviating insulin resistance
05/20/2008US7374914 Mismatch repair protein (MSH-5) for diagnosis, prognosis and treatment of cancer and urogenital disorders
05/20/2008US7374912 Nucleic acids encoding chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof
05/20/2008US7374911 Cytokine polypeptide for use in diagnosis, prevention and treatment of immunological and/or inflammatory disorders
05/20/2008US7374910 agonist; a memory function improving agent, appetite regulator; an uterine, renal, testis, spleen, heart, prostatic or skeletal muscle function improving agent; antiobesity agent, antiabetic
05/20/2008US7374909 mediated by receptors of the TNF/NGF superfamily of receptors; originally designated CBK, but now designated B1; DNA sequence: vector
05/20/2008US7374896 GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity
05/20/2008US7374895 Guanosine triphosphate (GTP) binding protein-coupled receptor proteins that bind histamine and are expressed in the brain
05/20/2008US7374894 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein
05/20/2008US7374892 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
05/20/2008US7374891 Receptor for Advanced Glycated Endproducts (RAGE); detecting binding of ligand and protein in presence of peptide, lipid, carbohydrate; amyloid, high-throughput colorimetric assay
05/20/2008US7374884 mutant alleles of the angiotensinogen (AGT) gene which cause susceptibility to insulin-dependent diabetes mellitus (IDDM); drug screening, diagnosis
05/20/2008US7374875 Peptides having affinity for the gp120 viral protein and use thereof
05/20/2008US7374872 CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection
05/20/2008US7374774 Electroprocessed material made by simultaneously electroprocessing a natural protein polymer and two synthetic polymers
05/20/2008US7374767 cyclic peptides blocking of the Casein Kinase II (CKII) phosphorylation domain; HPV-16 cervical carcinoma cells; peptides increase the sensitivity of the cells to the cytostatic effect of IFN
05/20/2008US7374765 Methods and compositions for diagnosis and treatment of iron misregulation diseases
05/20/2008US7374764 CD33-like protein
05/20/2008US7374761 Antigen-binding fragment (immunoglobulin) which bind to epitope of tumor necrosis factor (TNF) and inhibits its activity; diagnosis and treatment
05/20/2008US7374758 Fusion polypeptide capable of binding vascular endothelial growth factor (VEGF), wherein polypeptide consists of immunoglobulin-like (Ig) domain 2 of a first VEGF receptor and Ig domain 3 of a second VEGF receptor and multimerizing component; use in decreasing or inhibiting plasma leakage; eye disorders
05/20/2008US7374757 Fusion polypeptide capable of binding vascular endothelial growth factor (VEGF) to patient in need thereof, wherein polypeptide consists of immunoglobulin-like (Ig) domain 2 of a first VEGF receptor and Ig domain 3 of a second VEGF receptor and a multimerizing component; eye disorders
05/20/2008CA2611106A1 Anti-coronavirus molecules and their use in compositions and methods for treating and/or preventing infection caused by a coronavirus
05/20/2008CA2473759C Antibodies for detecting ecstasy-class analytes
05/20/2008CA2419698C Compounds, antibodies, reagent kits, methods of producing antibodies, and methods of detecting analytes
05/20/2008CA2363947C Hiv peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by hiv
05/20/2008CA2283231C Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same
05/20/2008CA2229202C Methods for identifying antagonist or agonist to human opioid receptor-like 1 "orl1"
05/20/2008CA2222755C Separation of hemoglobin on hydroxyapatite using hplc
05/20/2008CA2172630C Cellular and serum protein anchors and conjugates
05/15/2008WO2008058251A1 Variants and methods of using transforming growth factor beta-9
05/15/2008WO2008057961A2 Compositions and methods for the detection of trypanosoma cruzi infection
05/15/2008WO2008057461A2 Alk1 receptor and ligand antagonists and uses thereof
05/15/2008WO2008057162A2 Native (telopeptide) placental collagen compositions
05/15/2008WO2008057161A1 Avian derived erythropoietin
05/15/2008WO2008057144A2 Functional negative regulatory domain sequences from human notch1 and 2 and isolated lnr domains from human notch1
05/15/2008WO2008056840A1 Fibrinolytic metalloprotease and composition comprising the same
05/15/2008WO2008056726A1 Glp-1 derivative and use thereof
05/15/2008WO2008056543A1 Method for determination of presence or absence of peptide compound pyy3-36
05/15/2008WO2008056376A2 A recombinant meso-active thermo-stable protein and the process of design and biosynthesis thereof
05/15/2008WO2008056217A1 Process for the preparation of cyclic peptides
05/15/2008WO2008056155A1 Selective glucagon-like-peptide-2 (glp-2) analogues
05/15/2008WO2008056106A1 Transgenic non-human animal
05/15/2008WO2008055972A2 N-terminal pegylated prolactin receptor molecules